CN1069051C - Exterior-applied liniment for treating hyperosteogeny - Google Patents
Exterior-applied liniment for treating hyperosteogeny Download PDFInfo
- Publication number
- CN1069051C CN1069051C CN98124857A CN98124857A CN1069051C CN 1069051 C CN1069051 C CN 1069051C CN 98124857 A CN98124857 A CN 98124857A CN 98124857 A CN98124857 A CN 98124857A CN 1069051 C CN1069051 C CN 1069051C
- Authority
- CN
- China
- Prior art keywords
- gram
- radix aconiti
- medicine
- hyperosteogeny
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention discloses liniment externally applied for treating hyperosteogeny, which is prepared from raw sichuan axonite root, raw wild aconite root, safflower, Chinese azalea fruit, short-pedicel aconite root, borneol, spatholobus stem, etc. used as raw materials, and then distillate spirit is added for soak.
Description
The present invention is a kind of medicine for external use for the treatment of hyperosteogeny, is to be the externally-applied liniment that feedstock production forms with Chinese medicine specifically, belongs to the field of Chinese medicines.
Hyperosteogeny is the common disease in clinical, and multiple disease though this disease is not fatal, brings great inconvenience and misery for people's motion and life.The oral medicine of the treatment hyperosteogeny of Chu Shouing and medicine for external use all can only play and subtract the pain effect in the market, can not fundamentally treat this Gu Yuan effect that reaches.Serious hyperosteogeny takes operative treatment to have a big risk, and expensive consuming time, and the patient burden is heavy, and curative effect is not very good yet.
The medicine for external use that the purpose of this invention is to provide a kind of instant effect, good effect, treatment hyperosteogeny easy to use.
Hyperosteogeny motherland Chinese medicine claims that it is " arthromyodynia ", always just has or not " wetting " not become saying of numbness.The formation main cause of numbness is a blood stasis.The blood stasis cohesion is mutually bonding with periosteum, so become bony spur or be called hyperosteogeny.Its essence is exactly the barrier at bonding joint place after the blood stasis condensation, because the salient point of sticky object has been occupied the joint original interstice, therefore people are in motor activity, because constantly hitting, the convex protrusion thing of joint wipes extruding peripheral nerve on every side, thus produce pain, or motion is obstructed.For this reason, the inventor has proposed regulating qi to disperse stagnation, promoting blood circulation and stopping pain, expelling wind and removing dampness, the rule of treatment of killing parasites for relieving itching.According to this rule of treatment, invented following external used medicine.
Therefore, its crude drug composition of external used medicine of the present invention is:
Radix Aconiti 180-500 gram Radix Aconiti Kusnezoffii 250-6 00 gram Flos Carthami 3-8 gram
The last ligusticumic 75-350 gram of Flos Rhododendri Mollis 150-210 gram snow Borneolum Syntheticum 20-40 gram
Caulis Spatholobi 6-12 gram
The preferable amount proportioning of aforementioned pharmaceutical compositions each component is:
The last ligusticumic 75-150 gram of Radix Aconiti 180-350 gram Radix Aconiti Kusnezoffii 250-400 gram snow
Flos Rhododendri Mollis 150-210 gram Flos Carthami 4-6 gram Caulis Spatholobi 6-12 gram
Borneolum Syntheticum 20-35 gram
Another preferable amount proportioning of aforementioned pharmaceutical compositions each component is:
The last ligusticumic 250-350 gram of Radix Aconiti 250-500 gram Radix Aconiti Kusnezoffii 300-6 00 gram snow
Flos Rhododendri Mollis 150-210 gram Caulis Spatholobi 6-12 gram Flos Carthami 6-8 gram
Borneolum Syntheticum 20-40 gram
Another preferable amount proportioning of said medicine component each component is:
Radix Aconiti 300-450 gram Radix Aconiti Kusnezoffii 225-550 gram Flos Carthami 3-6 gram
The last ligusticumic 150-300 gram of Flos Rhododendri Mollis 150-210 gram snow Borneolum Syntheticum 20-30 gram
Caulis Spatholobi 6-12 gram
More than consumption and 50 kilograms of ashless soaking in Chinese liquor below 35 ℃ of each compositions can be made into externally-applied liniment.
The preparation method of externally-applied liniment of the present invention is as follows:
(1) by filling a prescription, wash used Chinese medicine decontamination, airing, section, oven dry are gone into crusher for crushing and are ground to form powdery, cross 60 mesh sieves, put the powder dry product of stating in a bulk container;
(2) pour 35 ℃ of ashless Chinese liquor of application quantity in the prescription in the above-mentioned container that is placed with the powder dry product, fully stirred 20 minutes, stir, stir once every day;
(3) summer is at room temperature, normal pressure, and indoor immersion three time-of-weeks, in room temperature soak five time-of-weeks at normal pressure winter;
(4) soak time up to standard after, sedimentation and filtration is received bottle with clean medicinal liquid.
Described ashless Chinese liquor is meant that grain wine does not add white lime in brewageing.
The using method of medicine of the present invention is:
A. seek the pain spot at bony spur place;
B. spray is put lotion of the present invention on the skin about 15 seconds, with three edged needle shallow pricking method (degree of depth is at 0.2mm) three pins on sore spot skin;
C. buckle cupping about 10 minutes, play a jar clear stasis of blood in the time of can seeing the atropurpureus clot in jar; Then look for pain spot to treat then again, repeatedly three times to five times promptly good.
The advantage of medicine of the present invention:
(1) be once breakthrough revolution to the hyperosteogeny traditional treatment, realized simple, quick, no pain, instant effect, the clinical common disease of the treatment that expense is few, the method for multiple disease; There is excellent popularization to be worth and prospect.
(2) types of medicines is few, as long as 7 kinds of Chinese medicines;
(3) curative effect is fast, and treatment at once takes effect at once; The bony spur that knee joint is following, (comprising knee joint) 5-6 time just can fully recover with interior (promptly 18 days).Lumbar vertebra bone spur, cervical vertebra bony spur is takeed on all bony spur treatment time long slightly (approximately treat about 12-13 time, treatment in per three days is once) and can be fully recovered;
(4) Therapeutic Method is simple, is convenient to penetration and promotion.The method is convenient to penetration and promotion, as long as liquid medicine is arranged, explains above-mentioned A-C operational approach, and everybody can treating hyperosteogeny;
(5) being lower than the hospitalize cost, can alleviating patient economy burden, meet the reform policy of Health care system " the wide covering, the low guarantee ", is the good thing that part is benefited the nation and the people.
(6) cure rate height: this liquid medicine treatment hyperosteogeny obvious effective rate 100%, cure rate 99%;
(7) of many uses: A. is for traumatic injury, and athlete infantile myasthenia tissue damaged in play hinders cure rate 99%, obvious effective rate 100%;
B. for rheumatism, rheumatoid patient, this liquid medicine also is the ideal outer agent of applying ointment.
Embodiment 1
Prescription: a last ligusticumic 75 grams of Radix Aconiti 350 gram Radix Aconiti Kusnezoffii 250 gram snow
Flos Carthami 6 gram Caulis Spatholobis 12 gram Borneolum Syntheticums 30 grams
Flos Rhododendri Mollis 210 grams
The preparation solvent is the ashless Chinese liquor of 50 kilograms≤35 degree.
Sieve grinding into powder after the various prepared slices of Chinese crude drugs roguings sections by filling a prescription,, together pour in container with above-mentioned powder dry product Borneolum Syntheticum during making powder dry product and the ashless white spirit mixed of 50 kilograms≤35 degree, pour the ashless Chinese liquor of 50 kilograms≤35 degree into container then, stir 20 minutes evenly after, soak, stir once every day, each 20 minutes, soak time is three weeks of summer, winters five time-of-week, after soak time is up to standard, filter and remove residue taking liquid then, packing.
Indication: it is splendid that treatment hyperosteogeny and soft tissue injure the rheumatism effect outward, then focuses on rheumatism treatment aspect.
Embodiment 2
Prescription: a last ligusticumic 300 grams of Radix Aconiti Kusnezoffii 255 gram Radix Aconiti 4 50 gram snow
Flos Rhododendri Mollis 150 gram Flos Carthamis 6 gram Caulis Spatholobis 12 grams
Borneolum Syntheticum 20 grams
The preparation solvent is the ashless Chinese liquor of 50 kilograms≤35 degree.
Method for making: with embodiment 1
Indication: this prescription treatment hyperosteogeny is an optimum formula.
Embodiment 3
Prescription: a last ligusticumic 250 grams of Radix Aconiti 250 gram Radix Aconiti Kusnezoffii 600 gram snow
Flos Carthami 8 gram Borneolum Syntheticums 20 gram Flos Rhododendri Mollis 210 grams
Caulis Spatholobi 6 grams
The preparation solvent is the ashless Chinese liquor of 50 kilograms≤35 degree.
Method for making: with embodiment 1
Indication: this fills a prescription for rheumatism, rheumatoid, and athlete competition field damage pain is the person unbearably, after the agent of applying ointment, the race-entry of can entering the court after waiting for 15 seconds, rheumatism, rheumatoid is put affected area on the skin 3-5 time outward every day, by rubbing, with bitterly only drug withdrawal.
The clinical treatment example:
Example 1. field XX man 43 years old, Tongzhou District, Beijing cadre of industrial and commercial bureau
Suffer from lumbar vertebra hyperosteogeny pain unbearably, cause two lower limb muscles atrophy action unable, the life very important person looks after, and does not once have in how tame large hospital treatment and improves; My patient see a doctor February nineteen ninety, and the patient suffering can't bear during prescription on individual diagnosis, and am with a haggard face, pain can not be taken action unbearably, the obvious atrophy of the following muscle of waist, life wants the household to take care of, and treat after my diagnosis: (1) finds out the hyperosteogeny salient point, and the prescription of embodiment 2 is sprayed around salient point reaches; (2) with shallow point three pins of three edged needle; (3) buckle with No. 4 cupping jar, after treating 10 minutes, a large amount of purple clots appear, play surplus clot on jar removing skin this moment, then medicine is sprayed in proper order with same maneuver in front, rear, left and right near main sore spot, pricking method, button jar, rise jar wait treatment three times after, get home in pain relief 1.5 lis of just can walking with descending at once; Treatment in three days once lasts health recovery from illness in 67 days, does not violate so far.
Example 2. king XX woman 52 years old, Tongzhou District, Beijing family members of the Bureau of Finance
Suffer from two kneecap matter hypertrophy and had a surplus in 7 years, the equal bulging deformation in double knee joint front, rear, left and right can not have been squatted, and personal lifestyle is inconvenience very, and the various big hospital treatment state of an illness does not eliminate, and increases the weight of year by year, when June 9 nineteen ninety-five, idol was come my institute, is entered house by its lover's back of the body; I put double knee joint on the skin all around with the prescription spray of embodiment 1.Click three times (0.2 millimeter of the pricking method degree of depth) with three edged needle is shallow and detain a jar row stasis of blood then, wait 10 minutes blood stasis to extract, promptly play jar and remove a clot, after main pain spot pain disappears, in kind treat the bloated point of near the little pain spot of main pain spot, hypodynia point and acid; The patient leaves the bed and could move at do-it-yourself crouching station, continuous three times, praises at once and says: be " axcellent after the treatment that lasts 2 hours! ", treatment in later per three days is once treated altogether and is obtained recovery from illness for 6 times and violate so far.
3. XX men of example 62 years old, Tong Zhouqusong Zhuan Baimiao people from village, Beijing
Suffer from both feet and had a surplus in 3 years with end hyperosteogeny pain, slowly walk with crutches point foot on ordinary days, take a step forward whenever that it is pained all to sting, each tame hospital therapy unsatisfactory curative effect was sought medical advice to me at the beginning of 89 years 4 months; The patient look into into both feet with end hyperosteogeny, the bony spur growing point is middle part skin depth herein at the bottom of heel, and is thick and stiff, spray is soaked the medicine time behind the medicine and is about after half a minute button jar row's stasis of blood immediately, when treating about 10 minutes, blood stasis is promptly extracted, and even both feet have been walked freely with landing after three rows of row stasis of blood; Patient oneself walking is at once accompanied the family members that come and is thanked very much from institute.
Clinical statistics data: (from 1987--1997)
(1) hyperosteogeny patient 14,315 people that see a doctor, male 5730 people, the women: 8589 people, utilization pain point sprays the prescription cupping method of putting embodiment 1-3 on the skin, cure rate 100%;
(2) motion soft tissue injury patient sees a doctor: 626 people, and male 381 people, women 245 people, utilization spray medicine is rubbed pressing maneuver cure rate 100%;
(3) pain caused by ecchymoma person 158 people that see a doctor after the reduction of the fracture, male 152 people, women 6 people intend gauze and soak the treatment of medicine application, cure rate 100%.
As scheming:
The people treats the sex number imitates the pain classification | Number | Sex | Clinical efficacy | Administrated method | ||
The man | The woman | Recovery from illness | Cure rate | |||
Hyperosteogeny patient | 14,315 people | 5730 | 8589 | 14,315 | 100% | Pain point spray medicine cup row stasis of blood method |
Motion soft tissue injury patient | 626 | 381 | 245 | 826 | 100% | The spray medicine is rubbed pressing maneuver |
Pain caused by ecchymoma patient after the reduction of the fracture | 158 | 152 | 6 | 158 | 100% | Gauze soaks the medicine application |
Claims (4)
1. medicine for external use for the treatment of hyperosteogeny is characterized in that it is the externally-applied liniment that adds soaking in Chinese liquor system with following material medicine:
Radix Aconiti 180-500 gram Radix Aconiti Kusnezoffii 250-600 gram Flos Carthami 3-8 gram
The last ligusticumic 75-350 gram of Flos Rhododendri Mollis 150-210 gram snow Borneolum Syntheticum 20-40 gram
Caulis Spatholobi 6-12 gram.
2. according to the medicine for external use of claim 1, it is characterized in that the amount ratio of each material medicine is:
The last ligusticumic 75-150 gram of Radix Aconiti 180-350 gram Radix Aconiti Kusnezoffii 250-400 gram snow
Flos Rhododendri Mollis 150-210 gram Flos Carthami 4-6 gram Caulis Spatholobi 6-12 gram
Borneolum Syntheticum 20-35 gram.
3. according to the medicine for external use of claim 1, it is characterized in that the amount ratio of each material medicine is:
The last ligusticumic 250-350 gram of Radix Aconiti 250-500 gram Radix Aconiti Kusnezoffii 300-600 gram snow
Flos Rhododendri Mollis 150-210 gram Caulis Spatholobi 6-12 gram Flos Carthami 6-8 gram
Borneolum Syntheticum 20-40 gram.
4. according to the topical agent of claim 1, it is characterized in that the amount ratio of each material medicine is:
Radix Aconiti 300-450 gram Radix Aconiti Kusnezoffii 225-550 gram Flos Carthami 3-6 gram
The last ligusticumic 150-300 gram of Flos Rhododendri Mollis 150-210 gram snow Borneolum Syntheticum 20-30 gram
Caulis Spatholobi 6-12 gram.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98124857A CN1069051C (en) | 1998-11-23 | 1998-11-23 | Exterior-applied liniment for treating hyperosteogeny |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98124857A CN1069051C (en) | 1998-11-23 | 1998-11-23 | Exterior-applied liniment for treating hyperosteogeny |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1254579A CN1254579A (en) | 2000-05-31 |
CN1069051C true CN1069051C (en) | 2001-08-01 |
Family
ID=5228862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN98124857A Expired - Fee Related CN1069051C (en) | 1998-11-23 | 1998-11-23 | Exterior-applied liniment for treating hyperosteogeny |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1069051C (en) |
-
1998
- 1998-11-23 CN CN98124857A patent/CN1069051C/en not_active Expired - Fee Related
Non-Patent Citations (3)
Title |
---|
《实用中西医结合杂志》1991年4(9) 1991.9.30 吴大勇/中药制膏贴敷治疗骨质增生700例 * |
《甘肃中医学院落学报》1995年12(1) 1995.1.30 曾海菊/能质增生外敷方治疗腰椎骨质增生症87例 * |
《甘肃中医学院落学报》1995年12(1) 1995.1.30 曾海菊/能质增生外敷方治疗腰椎骨质增生症87例;《实用中西医结合杂志》1991年4(9) 1991.9.30 吴大勇/中药制膏贴敷治疗骨质增生700例 * |
Also Published As
Publication number | Publication date |
---|---|
CN1254579A (en) | 2000-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1698748A (en) | Externally applied pure Chinese medicine for treating spondylitis ankylopoietica and arthritis and its preparation method | |
CN1899403A (en) | Chinese medicine preparation for treating pains and its preparing method and use | |
CN1069051C (en) | Exterior-applied liniment for treating hyperosteogeny | |
CN1196491C (en) | Ointment for healing tranumatic injury fast | |
CN1876081A (en) | A medicinal tincture and method for preparing same | |
CN1256102C (en) | Powder for treating hyperosteogeny and protrusion of lumber and spondylopathy intervertebral disc and its preparation | |
CN1843441A (en) | Rheumatism-eliminating collaterals-dredging externally applied plaster | |
CN109529022A (en) | A kind of diabetic foot wound externally applied drug and its application method | |
CN1228064C (en) | Externally appied medicine for relieving pain and diminishing inflammation | |
CN1308024C (en) | Medicine for treating diabetes and its preparing method | |
CN101623336A (en) | External liniment for treating psoriasis | |
CN105456329A (en) | Rheumatism pain alleviating medicinal liquor | |
CN1236798C (en) | External medicine for treating bone tuberculosis | |
CN106729400A (en) | A kind of exterior-applied medical wine for the treatment of of arthritis | |
CN1319408A (en) | Medicated liquor for treating traumatic injury | |
CN101036672A (en) | Rheumatic oil | |
CN1247216C (en) | External used Chinese medicinal ointment for scald and its preparation | |
CN1281255C (en) | Medication for treating ulcer of lower limb of patients of skin disease and diabetic, and preparation method | |
CN1304027C (en) | Bone nourishing and rheumatic treating pills and their preparation | |
CN1224409C (en) | Medicinal wine for treating prolapse of lumbar intervertebral disc | |
CN100337669C (en) | Externally applied medicine for curing pain and process for preparing the same | |
CN100335111C (en) | Medicine for rheumatism and its preparation | |
CN1052162C (en) | Production method of traditional Chinese medicine pills for hyperostosis | |
CN1068523C (en) | Medicine for treating cancer and its preparing technology | |
CN1180816C (en) | Liniment for treating rheumarthritis and similar diseases and its prepn |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20010801 Termination date: 20101123 |